FOLIA HISTOCHEMICA ET CYTOBIOLOGICA, an esteemed journal published by VIA MEDICA, serves as a vital platform for researchers and professionals in the fields of histology, pathology, and cytobiology. With an ISSN of 0239-8508 and E-ISSN of 1897-5631, this Open Access journal has been disseminating significant findings since 1984, offering free access to a broad audience of scientists and academics. Based in Poland, this journal focuses on critical advancements in the study of cellular structures and functions, contributing substantially to the understanding of various diseases and biological processes. The journal currently holds a respectable impact factor, ranking in the Q3 category for Histology and miscellaneous Medicine, and Q2 for Pathology and Forensic Medicine as per the 2023 metrics. With its commitment to quality research and an inclusive publishing approach, FOLIA HISTOCHEMICA ET CYTOBIOLOGICA is poised to continue influencing its fields significantly through 2024 and beyond.

CONNECTIVE TISSUE RESEARCH is a distinguished academic journal published by Taylor & Francis Inc, dedicated to the study of connective tissue within a broad spectrum of biomedical fields. Since its inception in 1972, this journal has emerged as a crucial platform for disseminating high-quality research findings, exploring fundamental and applied aspects of connective tissue biology. With its convergence stretching to 2024, CONNECTIVE TISSUE RESEARCH showcases innovative research in areas such as biochemistry, orthopedics, rheumatology, and cell biology, making significant contributions to our understanding of tissue structure and function. The journal holds a commendable impact factor and ranks notably in various categories, including a Q2 status in Biochemistry and Orthopedics, reflecting its pivotal role in advancing knowledge in these fields. Researchers and professionals can benefit from its offerings, which include original articles, reviews, and cutting-edge studies, all aimed at enhancing scientific inquiry and clinical applications. The journal remains committed to promoting accessibility through traditional subscription options, ensuring its wide reach in the academic community.

Cell Death & Disease, published by SpringerNature, is a premier open-access journal dedicated to disseminating high-quality research on the mechanisms and implications of cell death, disease pathology, and therapeutic responses. Since its inception in 2010, the journal has quickly established itself within the top tier of academic publishing, achieving a notable impact factor and earning Q1 rankings in several critical categories including Cancer Research, Cell Biology, Cellular and Molecular Neuroscience, Immunology, and Medicine (miscellaneous). With its commitment to open access, Cell Death & Disease ensures that groundbreaking research is available to a global audience, fostering collaboration and advancing knowledge across disciplines. Residing at the forefront of crucial scientific discourse, this journal not only attracts submissions from leading researchers but also significantly influences the fields of molecular biology, immunology, and neurology. By bridging the gap between basic science and clinical applications, it provides vital insights for professionals, academicians, and students alike.

STEM CELLS AND DEVELOPMENT, published by Mary Ann Liebert, Inc., is a leading peer-reviewed journal dedicated to the rapidly advancing fields of stem cell biology and developmental science. With an ISSN of 1547-3287 and an E-ISSN of 1557-8534, the journal encompasses a broad range of topics central to understanding stem cells' roles in development and regeneration processes. It holds a prestigious standing within its category quartiles, ranking Q3 in Cell Biology, Q2 in Developmental Biology, and Q2 in Hematology for 2023. With its convergence from 2004 to 2024, STEM CELLS AND DEVELOPMENT fosters an innovative platform for researchers, professionals, and students to disseminate groundbreaking research, share insights, and explore novel therapeutic approaches. Open access options enhance the journal's visibility and accessibility, promoting a collaborative exchange of information among the scientific community. Positioned at the forefront of stem cell research and its applications, this journal is vital for anyone seeking to stay informed about the latest advancements and trends within these critical areas of study.

JOURNAL OF CELL BIOLOGY, published by Rockefeller University Press, stands as a leading authority in the fields of Cell Biology and Medicine, reflected by its esteemed Q1 ranking in both categories as of 2023. Established in 1955, this journal has become a pivotal platform for disseminating groundbreaking research that enhances our understanding of cellular processes and their implications in various biological contexts. With a broad scope that encompasses experimental and theoretical studies alike, the JOURNAL OF CELL BIOLOGY embraces a rich diversity of topics, making it essential reading for researchers, students, and professionals committed to advancing cellular research. Although the journal does not currently offer open access options, its robust reputation, underscored by a competitive Scopus ranking of 43 out of 285 in the Cell Biology category, ensures that published findings reach a wide audience and influence the ongoing discourse in the life sciences. For those interested in staying at the forefront of cell biological research, the JOURNAL OF CELL BIOLOGY represents a critical resource.

npj Regenerative Medicine, published by NATURE PORTFOLIO, is at the forefront of research and innovation in the field of regenerative medicine, fostering a deep understanding of cellular and molecular processes that can be leveraged for therapeutic advancements. Launched as an Open Access journal since 2016, it ensures wide dissemination of knowledge, allowing researchers, professionals, and students to access high-quality articles without barriers. With an impressive impact, it holds Q1 ratings across multiple categories including Biomedical Engineering, Cell Biology, Developmental Biology, and Medicine (miscellaneous) as of 2023, indicating its critical role in shaping contemporary scientific discourse. The journal ranks notably within the top 10% in multiple Scopus categories, indicating its commitment to publishing pioneering research that addresses pressing challenges in regenerative therapies. Addressing the dynamic convergence of disciplines, npj Regenerative Medicine is poised to not only impact academic thought but also translate into clinical applications, making it a pivotal resource for those invested in the future of medicine.

Analytical Cellular Pathology, published by Hindawi Ltd, is a leading journal in the disciplines of Cancer Research, Cell Biology, and Pathology, and has been dedicated to advancing the field through open access since 1997. Based in Egypt, this journal plays a crucial role in disseminating cutting-edge research and innovative findings, fostering collaboration among researchers and professionals alike. With an impressive array of metrics, including its Q2 ranking in Pathology and Forensic Medicine and notable Scopus rankings, the journal attracts a diverse readership, ensuring significant impact in its categories. Designed to cater to the needs of both emerging and established scholars, Analytical Cellular Pathology promotes accessibility and exchange of knowledge, making it an indispensable resource for those engaged in modern cellular pathology research.

JOURNAL OF MUSCLE RESEARCH AND CELL MOTILITY, published by Springer, is a premier journal dedicated to advancing our understanding of muscle biology and cellular motility. With an ISSN of 0142-4319 and an E-ISSN of 1573-2657, this journal stands out in the fields of biochemistry, cell biology, and physiology, proudly holding a Q2 ranking in each of these categories as per 2023 metrics. Covering significant developments from its inception in 1963 to its anticipated contributions through 2024, this journal serves as a vital platform for researchers and professionals to disseminate their findings and insights globally. Although it does not currently offer open access, its robust academic rigor and relevance are evident from its Scopus rankings, making it a crucial resource for those invested in the biological sciences. With a focus on original research articles, reviews, and methodological advancements, the journal fosters innovative collaborations and discussions within the scientific community, making it an invaluable addition to any researcher’s library.

BMC Molecular and Cell Biology is a forward-thinking open-access journal published by BMC, specializing in the vital fields of molecular biology and cell biology. Since its inception in 2019, the journal has carved a niche for itself, ranking in the Q3 quartile in both Cell Biology and Molecular Biology categories as of 2023. With an ISSN of N/A and an E-ISSN of 2661-8850, the journal provides a platform for groundbreaking research, high-quality reviews, and innovative methodologies. Situated in the United Kingdom, BMC Molecular and Cell Biology promotes a diverse range of studies, addressing fundamental questions in biology that resonate with both experts and new researchers alike. The journal's commitment to open access ensures that valuable findings are readily available to the global scientific community, fostering collaboration and knowledge-sharing across disciplines. Researchers aiming to contribute to the field of cell and molecular biology will find this journal an indispensable resource for both publishing and staying informed on the latest advances.

DNA AND CELL BIOLOGY, published by Mary Ann Liebert, Inc, is a distinguished journal in the realms of cell biology, genetics, and molecular biology, holding a notable position in its Q3 and Q2 quartile rankings across multiple academic categories as of 2023. With an ISSN of 1044-5498 and an E-ISSN of 1557-7430, this journal has been a pivotal platform for the dissemination of cutting-edge research since its inception in 1990, extending its coverage through 2024. Situated in the United States, the journal offers high-quality peer-reviewed articles, exploring significant advancements in biological sciences while fostering interdisciplinary collaborations within the research community. Though it currently does not offer open access, subscribed institutions and individual readers benefit from its rich repository of knowledge. The journal's rigorous standards and impactful content make it an essential resource for researchers, professionals, and students alike, aiming to stay at the forefront of discoveries influencing DNA and cellular dynamics.